Profusa initiates strategic review to evaluate potential transactions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
May 5, 2026 8:30 AM EDTCompany focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities
Process intended to evaluate strategic growth alternatives to enhance scale, strengthen execution and support long-term shareholder value creation
BERKELEY, CA, May 05, 2026 (GLOBE NEWSWIRE) -- Â Profusa, Inc. (Profusa or the Company) (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, today announced that its Board of Directors has initiated a Board-led process to evaluate strategic alternatives intended to maximize shareholder value and support the Companys highest-priority commercial, regulatory and platform-expansion initiatives.
The process will evaluate a range of... More
